Quite recently, single-dose delivery of the SMN gene (SMN1 AC005031) to infants with spinal muscular atrophy (SMA) type 1 using Zolgensma (adeno-associated virus serotype 9) has been shown to be crucial for patients survival [33,34]. Here, SMN1 is linked to spinal muscular atrophy, type 1.